From October 1, 2022 to December 31, 2022, the company has repurchased 4,083,091 shares, representing 0.66% for $282.24 million. With this, the company has completed the repurchase of 11,264,878 shares, representing 1.81% for $1,000 million under the buyback announced on May 5, 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
92.32 USD | +1.36% |
|
-0.05% | +21.08% |
07-02 | Evercore ISI Adjusts Price Target on Edwards Lifesciences to $91 From $89, Maintains In-line Rating | MT |
07-01 | Edwards Lifesciences Corporation(NYSE:EW) added to Russell Top 200 Value Index | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.08% | 55.63B | |
+1.75% | 206B | |
+3.42% | 177B | |
+31.54% | 157B | |
+32.16% | 112B | |
+1.71% | 64.63B | |
-1.61% | 47.57B | |
-9.11% | 36.87B | |
-0.34% | 35.18B | |
+13.21% | 28.61B |
- Stock Market
- Equities
- EW Stock
- News Edwards Lifesciences Corporation
- Tranche Update on Edwards Lifesciences Corporation (NYSE: EW)'s Equity Buyback Plan announced on May 5, 2021.